A detailed history of Clean Yield Group transactions in Viatris Inc stock. As of the latest transaction made, Clean Yield Group holds 250 shares of VTRS stock, worth $3,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$3,250
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$8.77 - $10.85 $2,324 - $2,875
-265 Reduced 51.46%
250 $2,000
Q1 2023

Apr 26, 2023

SELL
$9.2 - $12.26 $1,720 - $2,292
-187 Reduced 26.64%
515 $4,000
Q3 2021

Oct 27, 2021

BUY
$13.25 - $15.13 $914 - $1,043
69 Added 10.9%
702 $10,000
Q2 2021

Jul 26, 2021

BUY
$12.97 - $16.15 $8,210 - $10,222
633 New
633 $9,000
Q1 2021

Apr 26, 2021

SELL
$13.59 - $18.54 $23,945 - $32,667
-1,762 Closed
0 $0
Q4 2020

Jan 26, 2021

BUY
$14.3 - $18.74 $25,196 - $33,019
1,762 New
1,762 $33,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.